NIH-funded research Career grant

Creating new cancer-fighting drugs using enzymes

Official title: Designing chemoenzymatic approaches to biologically active molecules enabled by enzyme library screening

Funded at University of Michigan at Ann Arbor · NIH-10876426 · Data updated 2026-11-12

This study is exploring how special proteins called enzymes can help create new medicines to fight cancer and infections, with the hope that these discoveries will lead to better treatments for patients like you.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$125,000
NIH project number5K99GM151479-02
Project IDNIH-10876426 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cancer or those at risk of infections who may benefit from novel therapeutic agents.

Less likely to help

Patients with conditions unrelated to cancer or infectious diseases may not receive direct benefits from this research.

What this research studies

This research focuses on using enzymes to create complex molecules that can be developed into new cancer treatments. By screening a library of enzymes, the team aims to discover new ways to synthesize biologically active compounds, particularly those that can fight infections and cancer. The approach involves studying natural processes in bacteria and fungi to guide the design of these molecules. Patients may benefit from innovative therapies that arise from this work, which could lead to more effective treatments for serious illnesses.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and more effective cancer therapies.

How similar studies have gone: Other research has shown success in using biocatalysis for drug development, indicating a promising avenue for this approach.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Smith, Kendrick Linwood — University of Michigan at Ann Arbor
  • Study coordinator: Smith, Kendrick Linwood

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.